Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
Regorafenib for Rectal Cancer
Recruiting1 awardPhase 2
Scottsdale, Arizona
This trial is studying how well lower-dose regorafenib works compared to standard dose regorafenib in treating patients with colorectal cancer that has spread to other places in the body and does not respond to treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service